Cothera Bioscience

Manufacturing · 11-50 Employees

View Company Info for Free

Overview

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Cothera Bioscience

Cothera Bioscience is a clinical stage biotech company focused on developing cancer therapies for previously undruggable oncology targets that address high unmet medical needs. The company utilizes a clinically validated translational platform that leverages synthetic lethality and protein degradation pathways to effectively target cancer cells. Founded by members of Crown Bioscience and experienced entrepreneurs from Silicon Valley, Cothera aims to innovate in the field of oncology. Their recent advancements include receiving Fast Track Designation from the FDA for their oral CDK9 inhibitor aimed at treating recurrent high-grade gliomas.Explore more
Popular SearchesCothera Bioscience IncSIC Code 28,283NAICS Code 32,325Show more

Cothera Bioscience Org Chart

PhoneEmail
YC

Scientific Co-Founder

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Cothera Bioscience your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Cothera Bioscience

Compare insights from companies similar to Cothera Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Cothera Bioscience

<$5M
11-50
Private
-
-
YC
Yiyou ChenScientific Co-Founder
$6M
11-50
Private
$27.1M
2009
<$5M
11-50
Private
$13.7M
2008
JF
Jason FrazierVice President, Scientific Operations
<$5M
11-50
Private
-
1998
N/A
<$5M
11-50
Private
-
-
SS
Sanjeev SharmaDeputy Director (Engg)
<$5M
1-10
Private
<$5M
2002
SG
Sagar GalwankarGlobal Operations Vice President, Marketing
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Cothera Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Cothera Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cothera Bioscience.

Cothera Bioscience Tech Stack

A closer look at the technologies used by Cothera Bioscience

Top Manufacturing Companies

Frequently Asked Questions Regarding Cothera Bioscience

What is Cothera Bioscience's official website?
Cothera Bioscience's official website is www.cotherabio.com
What is Cothera Bioscience's Revenue?
Cothera Bioscience's revenue is <$5 Million
What is Cothera Bioscience's SIC code?
Cothera Bioscience's SIC: 28,283
What is Cothera Bioscience's NAICS code?
Cothera Bioscience's NAICS: 32,325
How many employees does Cothera Bioscience have?
Cothera Bioscience has 11-50 employees
What industry does Cothera Bioscience belong to?
Cothera Bioscience is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Cothera Bioscience competition?
Cothera Bioscience top competitors include: TransGenex Nanobiotech, Ddnews, Pharmatest Services, Kiyatec
What technology does Cothera Bioscience use?
Some of the popular technologies that Cothera Bioscience uses are: WordPress.org, PHP, Google Font API, Font Awesome
What does Cothera Bioscience do?

Cothera Bioscience is a clinical stage biotech company focused on developing cancer therapies for previously undruggable oncology targets that address high unmet medical needs. The company utilizes a clinically validated translational platform that leverages synthetic lethality and protein degradation pathways to effectively target cancer cells. Fo... unded by members of Crown Bioscience and experienced entrepreneurs from Silicon Valley, Cothera aims to innovate in the field of oncology. Their recent advancements include receiving Fast Track Designation from the FDA for their oral CDK9 inhibitor aimed at treating recurrent high-grade gliomas.Read More

Is Cothera Bioscience a public company?
Cothera Bioscience is private company therefore does not currently have an official ticker symbol
See more information about Cothera Bioscience

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.